✉news HealthMedicine first seen 18 h ago, last 5 h ago, peak #37

Platform Trials Are Rewriting the Rules of Medical Evidence

Original: Platform Trials Are Rewriting the Rules of Evidence. Regulators Haven’t Caught Up.

Platform trials, which test multiple treatments against a single control group, are changing how clinical evidence is generated in medicine. Commentators argue that regulators have not yet adapted their standards to this trial design, raising questions about how such evidence will be assessed for drug approvals.

Why now: Ongoing debate about whether drug regulators can properly evaluate evidence from newer multi-treatment trial designs

drug regulatorsplatform trialspharmaceutical industry

Open on news →

Rank over time, top of the chart is #1. 11 snapshots from 18 h ago to 5 h ago.

Evidence

• Platform Trials Are Rewriting the Rules of Evidence. Regulators Haven’t Caught Up. · The Clinical Trial Vanguard

API: https://socialmediatrends-api.osmike.com/v1/trends/86921